GAINESVILLE, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- X-tosis, Inc., a pre-clinical biotech company transforming the treatment ...

MYOS Corp., a leader in proactive muscle health supplements, encourages partnering with your pet to achieve shared longevity ...

Primo Biotechnology (“Primo”) today announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader ...

For those who prefer a discreet way to consume THC, Black Tie CBD’s THC gummies are the perfect choice. Each gummy is infused ...

“The new KL1v represents more than just an update – it’s a testament to Capsa Healthcare’s unwavering commitment to innovation and excellence in pharmacy automation,” said Huan K. Nguyen, R.Ph., VP of ...

As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035. CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceut ...

AdhereTech, Inc., the market-leading provider of real-time medication adherence solutions proven to help patients remain compliant with clinical study protocols and adherent with prescribed dosing ...

Kingswood Capital Partners, LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and VCL Law LLP ...

BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi ...

I welcome the opportunity of sharing novel information about our company and the secreted form of the Klotho anti-aging gene, ’s-KL’, the patent protected development platform on which our product ...

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CEO, and Sam ...

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022.